205
Views
24
CrossRef citations to date
0
Altmetric
Articles

Post-treatment with a heat shock protein 90 inhibitor prevents chronic lung injury and pulmonary fibrosis, following acute exposure of mice to HCl

, , , & ORCID Icon
Pages 203-216 | Received 03 Dec 2019, Accepted 29 Apr 2020, Published online: 13 May 2020

References

  • Kuligowski E. Compilation of Data on the Sublethal Effects of Fire Effluent. National Institute of Standards and Technology; 2009;1(5.2.1):14–16.
  • National Research Council. Assessment of Exposure-Response Functions for Rocket-Emission Toxicants. Washington, DC: The National Academies Press; 1998.
  • National Research Council. Acute Exposure Guideline Levels for Selected Airborne Chemicals. Washington, DC: The National Academies Press 2014.
  • Kilburn KH. Effects of a hydrochloric acid spill on neurobehavioral and pulmonary function. J. Occup. Environ. Med.. 1996;38(10):1018–1031. doi:10.1097/00043764-199610000-00012.
  • Bingham E, Cohrssen B, Powell CH. Patty’s Toxicology. New York, NY: John Wiley & Sons 2001.
  • Agabiti N, Ancona C, Forastiere F, et al. Short term respiratory effects of acute exposure to chlorine due to a swimming pool accident. Occup. Environ. Med. 2001;58(6):399–404. doi:10.1136/oem.58.6.399.
  • Promisloff RA, Phan A, Lenchner GS, et al. Reactive airway dysfunction syndrome in three police officers following a roadside chemical spill. Chest. 1990;98(4):928–929. doi:10.1378/chest.98.4.928.
  • Boyce SH, Simpson KA. Hydrochloric acid inhalation: Who needs admission?. Journal of Accident & Emergency Medicine. 1996;13(6):422–424. doi:10.1136/emj.13.6.422.
  • Deschamps D, Soler P, Rosenberg N, et al. Persistent asthma after inhalation of a mixture of sodium hypochlorite and hydrochloric acid. Chest. 1994;105(6):1895–1896. doi:10.1378/chest.105.6.1895.
  • Reiss LK, Uhlig U, Uhlig S. Models and mechanisms of acute lung injury caused by direct insults. Eur J Cell Biol. 2012;91(6-7):590–601. doi:10.1016/j.ejcb.2011.11.004.
  • Setzer F, Schmidt B, Hueter L, et al. Characterization of the seven-day course of pulmonary response following unilateral lung acid injury in rats. PLoS One. 2018;13(6):e0198440. doi:10.1371/journal.pone.0198440.
  • Amigoni M, Bellani G, Scanziani M, et al. Lung injury and recovery in a murine model of unilateral acid aspiration: functional, biochemical, and morphologic characterization. Anesthesiology. 2008;108(6):1037–1046. doi:10.1097/ALN.0b013e318173f64f.
  • Patel BV, Wilson MR, Takata M. Resolution of acute lung injury and inflammation: a translational mouse model. Eur Respir J. 2012;39(5):1162–1170. doi:10.1183/09031936.00093911.
  • Yano T, Deterding RR, Simonet WS, et al. Keratinocyte growth factor reduces lung damage due to acid instillation in rats. Am J Respir Cell Mol Biol. 1996;15(4):433–442. doi:10.1165/ajrcmb.15.4.8879176.
  • Marinova M, Solopov P, Dimitropoulou C, et al. Acute exposure of mice to hydrochloric acid leads to the development of chronic lung injury and pulmonary fibrosis. Inhalation Toxicol. 2019;31(4):147–114. doi:10.1080/08958378.2019.1624895.
  • White ES, Mantovani AR. Inflammation, wound repair, and fibrosis: reassessing the spectrum of tissue injury and resolution. J Pathol. 2013;229(2):141–144. doi:10.1002/path.4126.
  • Thannickal VJ, Toews GB, White ES, et al. Mechanisms of pulmonary fibrosis. Annu Rev Med. 2004;55(1):395–417. doi:10.1146/annurev.med.55.091902.103810.
  • Sontake V, Wang Y, Kasam RK, et al. Hsp90 regulation of fibroblast activation in pulmonary fibrosis. JCI Insight. 2017;2(4):e91454. doi:10.1172/jci.insight.91454.
  • Lanneau D, Wettstein G, Bonniaud P, et al. Heat shock proteins: cell protection through protein triage. Scient World J. 2010;10:1543–1552. doi:10.1100/tsw.2010.152.
  • Houck SA, Singh S, Cyr DM. Cellular responses to misfolded proteins and protein aggregates. Methods Mol Biol. 2012;832:455–461. doi:10.1007/978-1-61779-474-2_32.
  • Kryeziu K, Bruun J, Guren TK, et al. Combination therapies with HSP90 inhibitors against colorectal cancer. Biochim Biophys Acta (BBA) – Rev Cancer. 2019;1871(2):240–247. doi:10.1016/j.bbcan.2019.01.002.
  • Shrestha L, Bolaender A, Patel HJ, et al. Heat shock protein (HSP) drug discovery and development: targeting heat shock proteins in disease. CTMC. 2016;16(25):2753–2764. doi:10.2174/1568026616666160413141911.
  • Vancheri C, Failla M, Crimi N, et al. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J. 2010;35(3):496–504. doi:10.1183/09031936.00077309.
  • Vancheri C. Common pathways in idiopathic pulmonary fibrosis and cancer. Eur Respir Rev. 2013;22(129):265–272. doi:10.1183/09059180.00003613.
  • Sibinska Z, Tian X, Korfei M, et al. Amplified canonical transforming growth factor-β signalling via heat shock protein 90 in pulmonary fibrosis. Eur Respir J. 2017;49(2):1501941. doi:10.1183/13993003.01941-2015.
  • Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41(4):467–470. doi:10.1136/jcp.41.4.467.
  • Veres-Székely A, Pap D, Sziksz E, et al. Selective measurement of α smooth muscle actin: why β-actin can not be used as a housekeeping gene when tissue fibrosis occurs. BMC Molec Biol. 2017;18(1):12. doi:10.1186/s12867-017-0089-9.
  • Boulet L-P. Increases in airway responsiveness following acute exposure to respiratory irritants: reactive airway dysfunction syndrome or occupational asthma?. Chest. 1988;94(3):476–481. doi:10.1378/chest.94.3.476.
  • Yuno A, Lee M-J, Lee S, et al. Clinical evaluation and biomarker profiling of Hsp90 inhibitors. In: Calderwood SK, Prince TL, (Eds). Chaperones: Methods and Protocols. New York, NY: Springer New York; 2018. p. 423–441.
  • National Institutes of Health US. https://clinicaltrials.gov/.
  • Neckers L, Workman P. Hsp90 molecular chaperone inhibitors: are we there yet? Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. 2012;18(1):64–76. doi:10.1158/1078-0432.CCR-11-1000.
  • Jhaveri K, Chandarlapaty S, Iyengar N, et al. Biomarkers that predict sensitivity to heat shock protein 90 inhibitors. Clinical Breast Cancer. 2016;16(4):276–283. doi:10.1016/j.clbc.2015.11.004.
  • Esfahani K, Cohen V. HSP90 as a novel molecular target in non-small-cell lung cancer. Lung Cancer (Auckland, NZ. ). 2016;7:11–17.
  • Felip E, Barlesi F, Besse B, et al. Phase 2 Study of the HSP-90 Inhibitor AUY922 in previously treated and molecularly defined patients with advanced non–small cell lung cancer. Journal of Thoracic Oncology. 2018;13(4):576–584. doi:10.1016/j.jtho.2017.11.131.
  • Hiemstra PS, McCray PB, Bals R. The innate immune function of airway epithelial cells in inflammatory lung disease. Eur Respir J. 2015;45(4):1150–1162. doi:10.1183/09031936.00141514.
  • Parker D, Prince A. Innate Immunity in the Respiratory Epithelium. Am J Respir Cell Mol Biol. 2011;45(2):189–201. doi:10.1165/rcmb.2011-0011RT.
  • Scotton CJ, Chambers RC. Bleomycin revisited: towards a more representative model of IPF?. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2010;299(4):L439–L441. doi:10.1152/ajplung.00258.2010.
  • Izbicki G, Segel MJ, Christensen TG, et al. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol. 2002;83(3):111–119. doi:10.1046/j.1365-2613.2002.00220.x.
  • Homer RJ, Elias JA, Lee CG, et al. Modern concepts on the role of inflammation in pulmonary fibrosis. Arch Pathol Lab Med. 2011;135(6):780–788. doi:10.1043/2010-0296-RA.1.
  • Lilja A, Weeden CE, McArthur K, et al. HSP90 Inhibition Suppresses Lipopolysaccharide-Induced Lung Inflammation In Vivo. Plos One. 2015;10(1):e0114975. doi:10.1371/journal.pone.0114975.
  • Bonniaud P, Kolb M, Galt T, et al. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J. Immunol. 2004;173(3):2099–2108. doi:10.4049/jimmunol.173.3.2099.
  • Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325–338. doi:10.1038/nrneph.2016.48.
  • Madala SK, Schmidt S, Davidson C, et al. MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation. Am J Respir Cell Mol Biol. 2012;46(3):380–388. doi:10.1165/rcmb.2011-0237OC.
  • Dong H, Luo L, Zou M, et al. Blockade of extracellular heat shock protein 90α by 1G6-D7 attenuates pulmonary fibrosis through inhibiting ERK signaling. Amer. J. Physiol.–Lung C. 2017;313(6):L1006–L1015. doi:10.1152/ajplung.00489.2016.
  • Jeffrey Leavitt J, Whalen R, Veraldi K, et al. Role of heat shock proteins in modulating ECM deposition. The FASEB J. 2015;29(1_supplement)925.921.
  • Decaris ML, Gatmaitan M, FlorCruz S, et al. Proteomic analysis of altered extracellular matrix turnover in bleomycin-induced pulmonary fibrosis. Mol Cell Proteomics. 2014;13(7):1741–1752. doi:10.1074/mcp.M113.037267.
  • Mayor-López L, Tristante E, Carballo-Santana M, et al. Comparative Study of 17-AAG and NVP-AUY922 in pancreatic and colorectal cancer cells: are there common determinants of sensitivity? . Transl Oncol. 2014;7(5):590–604. doi:10.1016/j.tranon.2014.08.001.
  • Kim SH, Kang JG, Kim CS, et al. Novel heat shock protein 90 inhibitor NVP-AUY922 synergizes with the histone deacetylase inhibitor PXD101 in induction of death of anaplastic thyroid carcinoma cells. J Clin. Endocrinol. Metab. 2015;100(2):E253–E261. doi:10.1210/jc.2014-3101.
  • Buchegger K, Silva R, Lopez J, et al. The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer. Pathol Res Pract. 2017;213(5):476–482. doi:10.1016/j.prp.2017.01.025.
  • Dou F, Yuan LD, Zhu JJ. Heat shock protein 90 indirectly regulates ERK activity by affecting Raf protein metabolism. Acta Biochim. Biophys. Sin. 2005;37(7):501–505. doi:10.1111/j.1745-7270.2005.00069.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.